Literature DB >> 2646983

Is clonidine useful in the treatment of alcohol withdrawal?

B J Robinson1, G M Robinson, T J Maling, R H Johnson.   

Abstract

The comparative efficacy of clonidine and chlormethiazole has been examined in the management of acute alcohol withdrawal. A double blind randomized study was conducted in consecutive patients admitted to a hospital detoxification unit. Patients were assessed regularly by a standard alcohol withdrawal rating-scale. Thirty-two patients received either clonidine or chlormethiazole in reducing dosages over 96 hr. All the patients receiving chlormethiazole had uneventful withdrawals. However, eight patients treated with clonidine were withdrawn from the trial due to hallucinations (two), seizures (two), symptomatic orthostatic hypotension (three) or drowsiness (one), indicating that clonidine is less effective than chlormethiazole in the prevention of the major manifestations of alcohol withdrawal.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2646983     DOI: 10.1111/j.1530-0277.1989.tb00290.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  8 in total

1.  Action of chlormethiazole in a model of ethanol withdrawal.

Authors:  A R Green; E M Davies; H J Little; M A Whittington; A J Cross
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 2.  Managing alcohol withdrawal in the elderly.

Authors:  K L Kraemer; J Conigliaro; R Saitz
Journal:  Drugs Aging       Date:  1999-06       Impact factor: 3.923

Review 3.  Seizures in alcohol-dependent patients: epidemiology, pathophysiology and management.

Authors:  Matti Hillbom; Ilkka Pieninkeroinen; Maurizio Leone
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 4.  Critical care pharmacotherapy. A review.

Authors:  M Tryba; P J Kulka
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

Review 5.  Recommended drug treatment strategies for the alcoholic patient.

Authors:  A Schaffer; C A Naranjo
Journal:  Drugs       Date:  1998-10       Impact factor: 9.546

6.  [Guideline-oriented treatment of alcohol-related disorders].

Authors:  K Mann; E Hoch; A Batra; U Bonnet; A Günthner; G Reymann; M Soyka; N Wodarz; M Schäfer
Journal:  Nervenarzt       Date:  2016-01       Impact factor: 1.214

7.  Dexmedetomidine as adjunct treatment for severe alcohol withdrawal in the ICU.

Authors:  Samuel G Rayner; Craig R Weinert; Helen Peng; Stacy Jepsen; Alain F Broccard
Journal:  Ann Intensive Care       Date:  2012-05-23       Impact factor: 6.925

Review 8.  Neuropsychiatric consequences of cardiovascular medications.

Authors:  Jeff C Huffman; Theodore A Stern
Journal:  Dialogues Clin Neurosci       Date:  2007       Impact factor: 5.986

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.